EGFR and cholangiocarcinoma: Moreover, HB-EGF and amphiregulin as EGFR ligands are highly elevated in various types of cancer cells, including CC cells, and significantly enhances the survival of cancer cells by activation of EGFR and the extracellular-signal-regulated kinase (ERK) pathway [13].